Alex Efron

Investing Profile

Sweet spot: $15M Range: $8M–$35M

Telegraph Hill Partners thesis

Meet the Team View All J. Matthew Mackowski Chairman, Managing Director jmm@thpartners.net Matt has been a healthcare-focused venture capital investor since 1980 and began his career as an investment professional with Citicorp Venture Capital.  In 1991 he formed Mackowski & Shepler, the predecessor to Telegraph Hill Partners, and over nine years took an active or founding role with eight companies, primarily in medical and life science technologies.  Matt has represented THP on the boards of Althea Technologies (acquired by Ajinomoto), Ambion (acquired by Applied Biosystems), Asuragen (acquire

Sector and stage focus

  • Series B: Medical Devices, Health & Hospital Services, Consumer Health, Diagnostics, Drug Delivery, Digital Health, Health IT
  • Series A: Medical Devices, Consumer Health, Health IT, Health & Hospital Services, Drug Delivery, Diagnostics, Digital Health
  • general: Investors who invested in female founders, Investors who were founders, Investors who invested in diverse founders, San Francisco Bay Area

Is Alex Efron a fit for your round?

Upload your pitch deck and see whether Alex Efron appears in your top 20 matches.

Find investors for your deck